These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 1242637)

  • 21. Species difference in drug metabolism by liver microsomes in alloxan diabetic or fasted animals. I. The activity of drug-metabolizing enzymes and electron transport system.
    Kato R; Onoda K; Takanaka A
    Jpn J Pharmacol; 1970 Dec; 20(4):546-53. PubMed ID: 5312936
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of aromatic nitro compounds on oxidative metabolism by cytochrome P-450 dependent enzymes.
    Sternson LA; Gammans RE
    J Med Chem; 1976 Jan; 19(1):174-7. PubMed ID: 1246040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of clofibrate (ethyl-4-chlorophenoxyisobutyrate) on hepatic drug metabolism in male rats.
    Lewis NJ; Witiak DT; Feller DR
    Proc Soc Exp Biol Med; 1974 Jan; 145(1):281-5. PubMed ID: 4812862
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of low protein diet on sleeping time and on the metabolism of hexobarbital in rats.
    Czyzewska-Szafran H; Lastowska K; Obojska K; Wutkiewicz M
    Pol J Pharmacol Pharm; 1975; 27(6):625-30. PubMed ID: 1208235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of furazolidone on duration of righting reflex loss induced with hexobarbital and zoxazolamine in the rat.
    Sasaki N
    J Vet Med Sci; 1994 Aug; 56(4):667-70. PubMed ID: 7999888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of adrenalectomy or alloxan diabetes on the substrate interaction with cytochrome P-450 in the oxidation of drugs by liver microsomes.
    Kato R; Takanaka A; Onoda K
    Biochem Pharmacol; 1971 Feb; 20(2):447-58. PubMed ID: 5150143
    [No Abstract]   [Full Text] [Related]  

  • 27. Species and sex differences in selenium inhibition of hepatic drug metabolism in rodents.
    Merrick BA; Johnson KL; Kester KA; Davies MH; Schnell RC
    Drug Chem Toxicol; 1983; 6(4):329-40. PubMed ID: 6617529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of thiamine consumption on liver microsomal drug-metabolizing pathways.
    Grosse W; Wade AE
    J Pharmacol Exp Ther; 1971 Mar; 176(3):758-65. PubMed ID: 4398746
    [No Abstract]   [Full Text] [Related]  

  • 29. Hepatic microsomal activities in rats with long and short sleeping times after hexobarbital: a comparison.
    Mitoma C; Neubauer SE; Badger NL; Sorich TJ
    Proc Soc Exp Biol Med; 1967 May; 125(1):284-8. PubMed ID: 6027543
    [No Abstract]   [Full Text] [Related]  

  • 30. Strain independent elevation of hepatic mono-oxygenase enzymes in female mice.
    Macleod JN; Sorensen MP; Shapiro BH
    Xenobiotica; 1987 Sep; 17(9):1095-102. PubMed ID: 3687065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diphenylhydantoin effect on neonatal and adult rat hepatic drug metabolism.
    Eling TE; Harbison RD; Becker BA; Fouts JR
    J Pharmacol Exp Ther; 1970 Jan; 171(1):127-34. PubMed ID: 5410930
    [No Abstract]   [Full Text] [Related]  

  • 32. Diphenylhydantoin effects on hexobarbital and aniline biotransformation in male rats: differences between in vitro and in vivo observations.
    Gut I; Becker BA
    Toxicol Appl Pharmacol; 1975 Nov; 34(2):253-8. PubMed ID: 1209623
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of liver microsome enzyme systems and barbiturate sleep times in rats caged individually or communally.
    Dairman W; Balazs T
    Biochem Pharmacol; 1970 Mar; 19(3):951-5. PubMed ID: 5507700
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of manganese on the hepatic microsomal mixed function oxidase enzyme system in the rat.
    Deimling MJ; Schnell RC
    Fundam Appl Toxicol; 1984 Dec; 4(6):1009-18. PubMed ID: 6519370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of rat hepatic microsomal enzymes by toxaphene pretreatment.
    Trottman CH; Desaiah D
    J Environ Sci Health B; 1980; 15(1):121-34. PubMed ID: 6766963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic and environmental factors affecting hexobarbital metabolism in mice.
    Vesell ES
    Ann N Y Acad Sci; 1968 Jul; 151(2):900-12. PubMed ID: 5263697
    [No Abstract]   [Full Text] [Related]  

  • 37. The effects of estrus cycle on drug metabolism in the rat.
    Brandstetter Y; Kaplanski J; Leibson V; Ben-Zvi Z
    Eur J Drug Metab Pharmacokinet; 1986; 11(4):251-4. PubMed ID: 3582419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The diphasic action of halothane on the oxidative metabolism of drugs by the liver. An in-vitro study in the rat.
    Brown BR
    Anesthesiology; 1971 Sep; 35(3):241-6. PubMed ID: 5095536
    [No Abstract]   [Full Text] [Related]  

  • 39. Inhibition of hepatic microsomal drug metabolism in rats by five calcium antagonists.
    Mäenpää J; Ruskoaho H; Pelkonen O
    Pharmacol Toxicol; 1989 May; 64(5):446-50. PubMed ID: 2771871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of manganese on hepatic drug metabolism in male and female rats.
    Schnell RC; Deimling MJ
    Res Commun Chem Pathol Pharmacol; 1984 Feb; 43(2):307-15. PubMed ID: 6709965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.